2022 American Transplant Congress » Liver: Hepatocellular Carcinoma and Other Malignancies

7:00pm-8:00pm

A Intention-to-Treat Analysis of 881 Consecutively Waitlisted Patients to Develop a Survival Benefit Model for Hepatocellular Carcinoma Liver Transplant Candidates

B. V. Tran¹, W. Lapisatepun¹, W. Dumronggittigule¹, D. Markovic², Y. Lee¹, F. Kaldas¹, D. Farmer¹, R. Busuttil¹, V. Agopian¹

7:00pm-8:00pm

An International Multi-Institutional Comparison of Liver Transplantation for Hepatocellular Carcinoma: United States, United Kingdom, and Canada

T. Ivanics¹, D. Wallace², M. P. Claasen³, M. Patel⁴, W. Jassem⁵, K. Menon⁵, A. Suddle⁵, N. Heaton⁵, N. Mehta⁶, J. van der Meulen², G. Sapisochin³

7:00pm-8:00pm

Characterizing Outcomes of Patients with Colorectal Liver Metastases (CRLM) Undergoing Liver Transplantation (LT) Evaluation

E. Takoushian¹, E. Brandon¹, B. Samstein², K. Halazun²

7:00pm-8:00pm

Everolimus in Liver Transplantation for Diffuse, Unresectable Neuroendocrine Tumor

J. M. Vanatta¹, R. A. Helmick², C. Eymard², N. Nezakatgoo², P. Horton², J. P. Kothadia², S. P. Nair², J. D. Eason²

7:00pm-8:00pm

Exploring Individual Optimal Immunosuppression Management According to the Oncological Risk in Liver Transplanted Patients with Hepatocellular Carcinoma

K. Sasakik¹, S. Kimura², D. Soma³, K. Tomiyama⁴, M. Matthew⁴, M. Fruscione², C. Kubal³, D. Kwon⁵

7:00pm-8:00pm

Higher Hepatocellular Carcinoma Tumor Burden Score is Associated with Grater Liver Transplant Survival Benefit

H. Liu¹, W. Zhang², M. Di³, H. Lee⁴, R. Cruz¹, X. Wang², C. Kaltenmeier¹, A. Thompson¹, D. Reddy¹, E. Ashwat¹, M. D'Alesio¹, S. Lebowitz¹, S. Tohme¹, D. Geller¹, A. Tevar¹, C. Hughes¹, A. Humar¹, J. Behari⁵, R. Bataller⁵, S. Hariharan⁵, M. Molinari¹

7:00pm-8:00pm

Immune Checkpoints, Immune Cells, and MHC Expression in the Tumor Microenvironment of Resected Hepatocellular Carcinomas

A. Baquerizo¹, V. Vavinskaya², S. Bagsic¹, A. Rojas³, A. Mhoyan⁴, C. Frenette¹, L. Sher⁵, M. Romero³, J. Fisher¹, C. Marsch¹, R. Schaffer¹

7:00pm-8:00pm

Impacts Of Donor Gender On Recurrent Hepatocellular Carcinoma In Liver Transplant Donated After Brain Death

T. Nakamura¹, K. Sasaki², T. Yamamoto¹, S. Kimura¹, L. Dageforde¹, H. Yeh¹, N. Elias¹, T. Kawai¹, J. F. Markmann¹

7:00pm-8:00pm

Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: An Analysis of the European Liver Transplant Registry

M. P. Claasen¹, T. Ivanics², J. N. IJzermans¹, G. Sapisochin², W. Polak¹

7:00pm-8:00pm

Liver Transplantation for Patients with Fibrolamellar Hepatocellular Carcinoma: A Comprehensive Multicenter Analysis to Support Future Decision Making

M. P. Claasen¹, T. Ivanics¹, W. G. Polak², J. N. IJzermans², G. Sapisochin¹

7:00pm-8:00pm

Locoregional Therapy and Long-Term Post-Transplant Outcomes for HCC Liver Transplant Recipients

T. Ishaque, S. R. Weeks, A. Kolarich, J. Ruck, J. Garonzik-Wang, D. Segev, A. Massie, B. King

7:00pm-8:00pm

Locoregional Therapy for Hepatocellular Carcinoma Decreases Liver Transplant Waitlist Dropout and Mortality

S. Weeks, T. Ishaque, A. Massie, D. Segev, E. King

7:00pm-8:00pm

Nivolumab After Sorafenib Failure in Liver Recipients with HCC Recurrence

J. Kwon

7:00pm-8:00pm

Outcomes of ABO-Incompatible Adult Living Donor Liver Transplantation for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria

B. Lee, J. Cho, H. Lee

7:00pm-8:00pm

The Impact of Yttium-90 Radioembolization on T Cell Phenotypes in Bridged to Transplant Hepatocellular Carcinoma Patients

K. Nunez, T. Sandow, P. Thevenot, A. Cohen

7:00pm-8:00pm

The Oncological Influences of Pre- and Post-Transplant Sustained Viral Response in Liver Transplant for Hepatocellular Carcinoma

K. Sasaki¹, S. Kimura², K. Tomiyama³, Y. Bekki⁴, M. Murray³, P. Huang³, M. Fruscione², A. Moro⁵, C. Kwon⁶

7:00pm-8:00pm

Tumor Suppressor Role of the Caveolar α1-na/k-atpase Signalosome in Nash Related Hepatocellular Carcinoma (HCC)

U. Udoh¹, M. Banerjee¹, J. D. Sanabria¹, P. K. Rajan¹, M. Schade², J. A. Sanabria³, S. Pierre³, J. R. Sanabria⁴